Literature DB >> 7694918

Effect of hearing enhancement on mental status ratings in geriatric psychiatric patients.

J L Kreeger1, M L Raulin, J Grace, B L Priest.   

Abstract

OBJECTIVE: This study looked at the impact of hearing deficits on the assessment of psychopathology in geriatric psychiatric patients.
METHOD: Psychiatric functioning and speech discrimination were measured in 21 elderly psychiatric patients in a crossover design.
RESULTS: Patients displayed less psychopathology when tested wearing a functioning hearing aid.
CONCLUSIONS: Gradual hearing loss may confound the assessment of psychopathology in geriatric psychiatric patients.

Entities:  

Mesh:

Year:  1995        PMID: 7694918     DOI: 10.1176/ajp.152.4.629

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Age-related hearing loss in older adults with cognitive impairment.

Authors:  Olivia Nirmalasari; Sara K Mamo; Carrie L Nieman; Allison Simpson; Jessica Zimmerman; Milap A Nowrangi; Frank R Lin; Esther S Oh
Journal:  Int Psychogeriatr       Date:  2016-09-22       Impact factor: 3.878

2.  Improving hearing and vision in dementia: protocol for a field trial of a new intervention.

Authors:  Jemma Regan; Piers Dawes; Annie Pye; Christopher J Armitage; Mark Hann; Ines Himmelsbach; David Reeves; Zoe Simkin; Fan Yang; Iracema Leroi
Journal:  BMJ Open       Date:  2017-11-28       Impact factor: 2.692

3.  Individualised sensory intervention to improve quality of life in people with dementia and their companions (SENSE-Cog trial): study protocol for a randomised controlled trial.

Authors:  Jemma Regan; Eric Frison; Fidéline Collin; Piers Dawes; Mark Hann; Ines Himmelsbach; Emma Hooper; David Reeves; Zoe Simkin; Chryssoula Thodi; Fan Yang; Iracema Leroi
Journal:  Trials       Date:  2019-01-25       Impact factor: 2.279

4.  A randomised controlled trial of hearing and vision support in dementia: Protocol for a process evaluation in the SENSE-Cog trial.

Authors:  Iracema Leroi; Christopher J Armitage; Fidéline Collin; Eric Frison; Mark Hann; Emma Hooper; David Reeves; Zoe Simkin; Lucas Wolski
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.